Most edited pathways

Showing below up to 50 results starting with #151.

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)

151. Homo sapiens:Parkinson's disease pathway ‎(52 revisions)
152. Homo sapiens:Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs) ‎(52 revisions)
153. Homo sapiens:Acute viral myocarditis ‎(52 revisions)
154. Homo sapiens:T-cell activation SARS-CoV-2 ‎(52 revisions)
155. Mus musculus:Splicing factor NOVA regulated synaptic proteins ‎(51 revisions)
156. Homo sapiens:Leucine, isoleucine and valine metabolism ‎(51 revisions)
157. Homo sapiens:Metapathway biotransformation Phase I and II ‎(51 revisions)
158. Homo sapiens:Type I interferon induction and signaling during SARS-CoV-2 infection ‎(51 revisions)
159. Rattus norvegicus:p53 pathway ‎(51 revisions)
160. Homo sapiens:Cerebral organic acidurias, including diseases ‎(51 revisions)
161. Homo sapiens:Melatonin metabolism and effects ‎(51 revisions)
162. Saccharomyces cerevisiae:Tricarboxylic acid cycle ‎(51 revisions)
163. Homo sapiens:Joubert syndrome ‎(51 revisions)
164. Homo sapiens:Ciliopathies ‎(51 revisions)
165. Homo sapiens:Ferroptosis ‎(51 revisions)
166. Homo sapiens:Disorders of fructose metabolism ‎(51 revisions)
167. Homo sapiens:Cori cycle ‎(50 revisions)
168. Homo sapiens:Sickle cell disease ‎(50 revisions)
169. Homo sapiens:Complement and coagulation cascades ‎(50 revisions)
170. Homo sapiens:IL23 inhibitors in inflammatory bowel disease ‎(50 revisions)
171. Homo sapiens:HIF1A and PPARG in hypertrophic cardiomyopathy ‎(50 revisions)
172. Homo sapiens:SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction ‎(50 revisions)
173. Mus musculus:Serotonin and anxiety ‎(50 revisions)
174. Homo sapiens:EGFR tyrosine kinase inhibitor resistance ‎(50 revisions)
175. Homo sapiens:VEGFA-VEGFR2 signaling ‎(49 revisions)
176. Homo sapiens:Synaptic vesicle pathway ‎(49 revisions)
177. Rattus norvegicus:Relationship between glutathione and NADPH ‎(49 revisions)
178. Homo sapiens:IL1 signaling ‎(49 revisions)
179. Homo sapiens:G1 to S cell cycle control ‎(49 revisions)
180. Homo sapiens:Estrogen metabolism ‎(49 revisions)
181. Danio rerio:FGF signaling pathway ‎(49 revisions)
182. Mus musculus:Distal convoluted tubule 1 (DCT1) cell ‎(49 revisions)
183. Homo sapiens:Regulation of actin cytoskeleton ‎(49 revisions)
184. Homo sapiens:Chromosomal and microsatellite instability in colorectal cancer ‎(48 revisions)
185. Homo sapiens:Oxidation by cytochrome P450 ‎(48 revisions)
186. Homo sapiens:Polycystic kidney disease pathway ‎(48 revisions)
187. Homo sapiens:Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione ‎(48 revisions)
188. Gallus gallus:Chicken limb development ‎(48 revisions)
189. Homo sapiens:Acetylcholine synthesis ‎(48 revisions)
190. Homo sapiens:Triacylglyceride synthesis ‎(48 revisions)
191. Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases ‎(48 revisions)
192. Homo sapiens:Vitamin D-sensitive calcium signaling in depression ‎(48 revisions)
193. Homo sapiens:Histone modifications ‎(48 revisions)
194. Homo sapiens:Extrafollicular and follicular B cell activation by SARS-CoV-2 ‎(48 revisions)
195. Homo sapiens:Cytokines and inflammatory response ‎(47 revisions)
196. Homo sapiens:Prion disease pathway ‎(47 revisions)
197. Homo sapiens:Complement activation ‎(47 revisions)
198. Homo sapiens:Fas ligand pathway and stress induction of heat shock proteins ‎(47 revisions)
199. Homo sapiens:Glyoxylate metabolism ‎(47 revisions)
200. Homo sapiens:Pathogenic Escherichia coli infection ‎(47 revisions)

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)